MedTrace Logo

Team Approach to Polypharmacy Evaluation and Reduction in a Long-Term Care Setting

NCT04055896 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-06-07

No results posted yet for this study

Summary

Medication side effects and interactions between medications are very common in older adults and are related to negative health outcomes. In this study, the investigators will test a new process aimed at reducing unnecessary medication use and drug side effects in seniors using the best medical evidence and patient preferences for treatment. This study will assess how feasible the implementation of this intervention is within a long-term care facility as well as if it is possible. Participants in two long-term care facilities will participate in this study. Measures will include feasibility outcomes regarding the logistics of the intervention as well as patients outcomes (falls, hospitalizations, and medications) collected before and after implementation. This trial will be a randomized control trial with an adaptive trial design.

Conditions

  • Long-term Care
  • Polypharmacy
  • Frailty

Interventions

OTHER

Medication Reduction

Systematic approach to reduction in polypharmacy

Sponsors & Collaborators

  • Labarge Optimal Aging

    collaborator UNKNOWN

  • Canadian Frailty Network

    collaborator OTHER

  • McMaster University

    lead OTHER

Principal Investigators

  • Dee Mangin, MBChB, DPH, FRNZC, MD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-15
Primary Completion
2021-03-30
Completion
2021-03-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04055896 on ClinicalTrials.gov